Invex Therapeutics Dividends and Buybacks
Dividend criteria checks 2/6
Invex Therapeutics is a dividend paying company with a current yield of 221.79%.
Key information
221.8%
Dividend yield
278.1%
Buyback Yield
| Total Shareholder Yield | 278.1% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if IXC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IXC's dividend payments have been increasing.
Dividend Yield vs Market
| Invex Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (IXC) | 221.8% |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.0% |
| Industry Average (Pharmaceuticals) | 2.3% |
| Analyst forecast (IXC) (up to 3 years) | n/a |
Notable Dividend: IXC's dividend (221.79%) is higher than the bottom 25% of dividend payers in the Australian market (2.65%).
High Dividend: IXC's dividend (221.79%) is in the top 25% of dividend payers in the Australian market (6.01%)
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate IXC's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as IXC has not reported any payouts.